Thu, August 6, 2020

Matthew Luchini Maintained (BLUE) at Buy with Decreased Target to $108 on, Aug 6th, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-108-on-aug-6th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Matthew Luchini of BMO Capital, Maintained "bluebird bio, Inc." (BLUE) at Buy with Decreased Target from $112 to $108 on, Aug 6th, 2020.

Matthew has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $73 on, Thursday, May 28th, 2020


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Decreased Target to $100 on, Monday, July 13th, 2020
  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Increased Target to $133 on, Friday, June 12th, 2020